Integrating Risk Management into Computer System Validation | IVT

The last decade has brought about a number of changes to how pharmaceutical companies address validation. These changes have been brought about primarily by regulatory changes and the economy. Rather than focusing on the “documented evidence” aspect of validation, companies and regulators are switching the focus to “where is the biggest risk” and managing thusly. In 2005, the International Conference on Harmonization (ICH) issued ICH Q9 Quality Risk Management and followed it up with ICH Q10 Quality Management Systems (2). These two documents along with ICH Q8 Pharmaceutical Development set the stage for using a risk-based approach to validation. In 2011, the European Commission revised Annex 11 to the European Union (EU) Good Manufacturing Practices (GMPs) to increase the focus on risk. The shift in focus to use of a risk-based approach and management responsibility should result in more appropriate validation efforts rather than “paperwork.”

This content is only available to IVT members.
Get help maintaining your knowledge in Computer & Software Validation. Read More!

If you are already a member and you do not have access to this article, upgrade your membership.
Need help? Read our FAQs.

Product Added Successfully

This product has been added to your account and you can access it from your dashboard. As a member, you are entitled to a total of 0 products.

Do you want access to more of our products? Upgrade your membership now!

Your Product count is over the limit

Do you want access to more of our products? Upgrade your membership now!

Product added to cart successfully.

You can continue shopping or proceed to checkout.